US expected to authorise Pfizer COVID jabs for 12 to 15 year olds

The United States’s regulator is expected to authorise Pfizer-BioNTech’s COVID-19 vaccine for children aged 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year. The announcement by the US Food and Drug Administration (FDA) is set to come a month after the company found that its shot, which is already authorised for those age 16 and older, also provided protection for the younger group.